Skip to main content

Table 4 Stock levels of test kits, lancets, drugs and needles and syringes for HIV and syphilis testing and treatment

From: Rollout of rapid point of care tests for antenatal syphilis screening in Ghana: healthcare provider perspectives and experiences

Consumables

Stock levels

Nil

< 1 month

≥1 month

Test kits and lancets

 Syphilis test kits (n = 13)a

6

0

7

 Syphilis test kits-chase buffer (n = 13)a

6

1

6

 HIV test kits/diluent (n = 14)b

0

4

10

 Lancets (n = 15)

1

0

14

Drugs and needles and syringes

 Injection Benzathine penicillin (n = 13)a

8

1

6

 Tablets Erythromycin (n = 13)a

7

0

8

 Syrup Nevirapine (n = 8)c

0

2

6

 Tablets Sulphadoxine pyrimethamine (n = 15)

2

1

12

 Needles and syringes (n = 15)

1

0

14

  1. a2 facilities which had not started syphilis screening were excluded; b1 facility which had not started antenatal HIV screening was excluded; c7 facilities that were not offering antiretroviral therapy (nevirapine) to babies of HIV positive mothers and referred all babies to other facilities for treatment were excluded